Paragon 28 (FNA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net revenue grew to $61.0 million, up 19.6%–20% year-over-year, driven by U.S. sales force expansion, international growth, and new product launches.
Launched 12 new products in the first seven months, with several in high-growth indications and a strong R&D pipeline.
Announced an operational efficiency strategy, including a 7% workforce reduction, executive compensation realignment, and cost controls, targeting up to $8M in annualized savings.
Appointed Chadi Chahine as CFO & EVP of Supply Chain Operations, effective August 5, 2024.
Filed restated financials for 2023 and Q1 2024 due to material inventory accounting errors.
Financial highlights
Q2 2024 global revenue reached $61.0 million, up 19.6%–20% year-over-year; U.S. revenue was $49.7 million (+17.6%–18%), international revenue $11.3 million (+29.4%).
Gross margin was 75.0%, down from 77.3% in Q2 2023, mainly due to higher supplier prices, inventory expenses, and international mix.
Adjusted EBITDA loss improved to -$3.0 million, a $2.4 million improvement year-over-year.
Net loss was $13.8 million, or $(0.17) per share, compared to $13.2 million, or $(0.16) per share, in Q2 2023.
Ended Q2 with $46.7 million in cash and $50 million available borrowing capacity; total debt was $110.6 million.
Outlook and guidance
2024 revenue guidance narrowed to $249M–$255M, representing 15.1%–17.8% growth, assuming stable FX rates.
Targeting EBITDA positivity in 2025 and cash flow positivity in 2026.
Operational efficiency initiatives expected to yield $8 million in annualized savings from headcount optimization.
Management expects existing cash, borrowing capacity, and revenues to fund operations for at least the next 12 months.
Monitoring macroeconomic and seasonal factors for potential impact on growth.
Latest events from Paragon 28
- Transformative product launches and digital platforms drive growth and efficiency targets.FNA
Canaccord Genuity 44th Annual Growth Conference2 Feb 2026 - Q3 revenue up 18.1% with first positive Adjusted EBITDA since IPO, but net loss and risks persist.FNA
Q3 202414 Jan 2026 - Product innovation and operational discipline drive growth and profitability targets for 2025.FNA
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Robust growth and innovation drive leadership ambitions in the foot and ankle market.FNA
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026